Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth

GW Pharmaceuticals

There's a lot at stake with a key public hearing later this week that's intended to help the FDA establish regulations for the U.S. hemp CBD industry.

What to Expect From the FDA's CBD Hearing

Cardinal Health

McKesson

Walgreens

I suggest that investors strive to build their portfolios based on prudent fundamental realities and not simply invest with the hope that your stocks will rise.

Medical Distributors: An Industry On Sale

Abercrombie & Fitch

Bed Bath & Beyond

Chico's FAS

Dollar Tree

FRED'S

Gap Inc

Landbridge Co LLC

Pier 1 Imports

Party City Holdco

The retail store closures just keep coming, from Dressbarn, CVS, Party City, Pier 1 Imports and more.

Dressbarn, CVS, Pier 1 and Topshop shuttering stores, pushing planned closures to 7,150

Uncertainty related to acquisitions and regulatory risk is putting downward pressure on CVS's stock.

CVS Looks Undervalued

Bank of New York Mellon

Kraft Heinz

Marathon Petroleum

According to GuruFocus' list of 52-week lows, these guru stocks have reached their 52-week lows.

6 stocks have reached their 52-week lows

The completed Aetna merger will be a positive catalyst for CVS stock. As a result, it's a strong prescription for long-term investors to consider
The post Does Progress On Aetna Integration Make CVS Health Stock A Buy In May?

Does Progress On Aetna Integration Make CVS Health Stock A Buy In May?

Heron Therapeutics

Illumina

Three Top Healthcare Stocks to Buy Right Now.

Merger uncertainty and corporate debt is already priced into CVS Health stock.

CVS Stock Faces Challenges With Aetna Merger … So Buy It!

Which retail pharma giant is the better choice for investors today?

Walgreens vs. CVS

Bristol-Myers

British American Tobacco

I'm a huge proponent of buying blue-chip dividend stocks at fair value or better. Sometimes the market offers quality companies at VERY large discounts to intrinsic value.

These 3 High-Yield Blue Chips Are Very Strong Buys

While CVS stock will likely hit a few bumps during the 2020 election cycle, it looks poised to deliver in the long-term.
The post Is CVS Stock A Deal or a Dud?

Is CVS Stock A Deal or a Dud?

CVS stock looks cheap on traditional valuation metrics. But it faces numerous severe obstacles in realizing that value.

CVS Stock Might Look Cheap, but It Is a Value Trap

After the recent earnings report we believe the long case has strengthened for CVS.

CVS: Trading Near Historic Lows Here

Investor optimism has been rising recently regarding CVS Health and its prospects.

CVS Health Is A Bargain

CVS Health Corporation reported Q1-2019 results that were better than the market expected.

CVS: Aetna Acquisition A Big Offset To Margin Pressures

Traders cheered when the healthcare conglomerate reported better-than-expected earnings and raised guidance.

Why CVS Health Is Moving Higher Today

All of the healthcare company's business segments delivered growth in the first quarter. Most of the growth, though, came from its acquisition of Aetna.

What's Behind CVS Health's Strong First-Quarter Earnings

Apple

The stock market rose Wednesday morning but was nervous about the coming news from the Fed.

Stock Market News: Apple Soars; CVS Looks Healthy

Year-over-year growth in CVS Health's (CVS) top line is aided by a strong Pharmacy Services segment, benefiting from the upside in specialty services.

CVS Health's (CVS) Q1 Earnings Top Estimates, EPS View Up

CVS Health Corporation (CVS) CEO Larry Merlo on Q1 2019 Results - Earnings Call Transcript

CVS Health Corp. released its first-quarter financial results before the markets opened on Wednesday.

How CVS Health Is Crushing It After Q1 Earnings

Apple and CVS Health pulled stock futures higher Wednesday as the Nasdaq looked for a rebound and markets awaited a Federal Reserve announcement.

Stock Futures Steer Higher As Apple and CVS Health received early earnings boosts

Shares of CVS Health Corp. CVS, +0.72% surged 4.5% in premarket trade Wednesday, after the drug store chain reported first-quarter profit, revenue and same-store sales that beat expectations, and lifted its full-year outlook.

CVS Health's stock surges after profit, revenue and same-store sales beat expectations

CVS Health on Wednesday reported results from its fiscal first quarter.

CVS Health beats first-quarter expectations, raises full-year forecast

Shares appear cheap on a fundamental and technical basis as CVS looks to show progress toward becoming a "health care hub."

News for CVS Health Stock (CVS)